Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease

Citation
Sj. Allen et al., Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease, BIOC BIOP R, 264(3), 1999, pp. 648-651
Citations number
27
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
ISSN journal
0006291X → ACNP
Volume
264
Issue
3
Year of publication
1999
Pages
648 - 651
Database
ISI
SICI code
0006-291X(19991102)264:3<648:PASLOC>2.0.ZU;2-Q
Abstract
Brain-derived neurotrophic factor (BDNF) is known to have trophic effects o n various neurons, throughout the brain and spinal cord, via its high-affin ity tyrosine kinase receptor TrkB. It has been reported that the mRNA for t his neurotrophin is reduced in Alzheimer's disease (AD) brain. We have exam ined, by Western blotting, the catalytic (p145) and noncatalytic or truncat ed (p95) forms of TrkB and find that, in both the temporal and frontal cort ex, there is a selective loss of immunoreactive-positive staining for the c atalytic or kinase form compared with the truncated form. This may have imp ortant consequences for the neurotrophic support of vulnerable neurons in A D. (C) 1999 Academic Press.